2025 has been a challenging year for advocates fighting for equitable access to care, as the CDC’s Advisory Committee on Immunization Practices has upended a legacy of science-based recommendations supported by the research community. In a particularly concerning move, ACIP removed its decades-long recommendation for the proven pediatric hepatitis B vaccine—a decision that puts millions of children at risk of long-term complications from this infectious disease.

Joining us to discuss the implications of ACIP’s latest action, and how advocacy organizations across the country are responding, is Scott Frey, Senior VP of Public Policy and Relations here at the Alliance.

Equitable access to treatment is vital for older adults with Alzheimer’s and other neurodegenerative diseases, especially in long-term care. CMS’s Long-Stay Antipsychotic Medication quality measure aimed to curb inappropriate use in nursing homes, but it has also led to unintended consequences, limiting safe, effective treatment options for more than 3 million residents.

A new Manatt Health report, supported by the Alliance’s Project PAUSE Coalition, explores these impacts and offers recommendations to restore equitable care. Joining us to discuss the findings are Chad Worz, CEO of the American Society of Consultant Pharmacists and Project PAUSE convener, and geriatric psychiatrist Dr. Amita Patel.

Open Enrollment season is here, and millions of Americans are hoping the latest formulary changes will help ease costs at the pharmacy counter. This month, the Alliance released several new resources, including an educational film, to help Medicare Part D beneficiaries make informed decisions for 2026.

Today, I’m joined by Adina Lasser, the Alliance’s Director of Public Policy and Government Relations, to discuss these new resources and break down what you need to know for this fall’s Medicare Open Enrollment, which runs from October 15 through December 7.